这是 Summit Therapeutics 的股票,下跌了16.47%。今天百分之一。更重要的是,该股今天收于低区间枢轴点下方。这告诉我,SMMT 股票在图表上正走向小幅下跌。
当你事先画好这些斐波那契回撤工具时,你就能相当清楚地看到——无需再画任何其他趋势线——9.54美元的786水平对应着先前的价格走势:价格突破该区间,然后回落,获得动能,随后再次向上飙升。
所以,这不过是对价格此前启动水平的回调,这告诉我,这就是价格走势可能的方向。看,我们的相对强弱指数(RSI)在34.91。如果我们到达786这个水平,我们肯定会测试30区间,也就是近期的超卖水平,这必然带来技术性反弹。
你需要一个技术上的理由。这正是那个理由。那个水平就是9.54美元的786斐波那契回撤位。
This was Summit Therapeutics' stock, which fell by 16.47%. One percent today. More importantly, the stock closed today below the low-range pivot point . This tells me that SMMT stock is heading for a slight decline on the charts.
When you draw these Fibonacci retracement tools beforehand, you can see quite clearly, without needing to draw any other trend lines, that the 786 level at $9.54 corresponds to the previous price action that broke through that range, then fell back, gained momentum, and then surged upwards again.
So, this is simply a correction to the level from which the price previously started, which tells me that this is the likely direction of price movement. Look, we are at 34.91 on the Relative Strength Index (RSI).
If we reach that level of 786, we will certainly test the 30 range, which is the near-term oversold level , which necessitates a technical bounce. You need a technical reason. That is precisely the reason .
That level is 786 Fibonacci retracement at $9.54.